HUP0004644A3 - Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase and pharmaceutical compositions containing them - Google Patents

Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase and pharmaceutical compositions containing them

Info

Publication number
HUP0004644A3
HUP0004644A3 HU0004644A HUP0004644A HUP0004644A3 HU P0004644 A3 HUP0004644 A3 HU P0004644A3 HU 0004644 A HU0004644 A HU 0004644A HU P0004644 A HUP0004644 A HU P0004644A HU P0004644 A3 HUP0004644 A3 HU P0004644A3
Authority
HU
Hungary
Prior art keywords
inhibitors
pharmaceutical compositions
compositions containing
neutrophil elastase
pyrrolopyrrolone
Prior art date
Application number
HU0004644A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9719189.4A external-priority patent/GB9719189D0/en
Priority claimed from GBGB9719183.7A external-priority patent/GB9719183D0/en
Priority claimed from GBGB9719290.0A external-priority patent/GB9719290D0/en
Priority claimed from GBGB9803611.4A external-priority patent/GB9803611D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of HUP0004644A2 publication Critical patent/HUP0004644A2/hu
Publication of HUP0004644A3 publication Critical patent/HUP0004644A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
HU0004644A 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase and pharmaceutical compositions containing them HUP0004644A3 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9719189.4A GB9719189D0 (en) 1997-09-09 1997-09-09 New therapeutic method
GBGB9719183.7A GB9719183D0 (en) 1997-09-09 1997-09-09 Compounds
GBGB9719290.0A GB9719290D0 (en) 1997-09-10 1997-09-10 Compounds
GBGB9803611.4A GB9803611D0 (en) 1998-02-21 1998-02-21 Compounds
PCT/EP1998/005609 WO1999012933A2 (en) 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase

Publications (2)

Publication Number Publication Date
HUP0004644A2 HUP0004644A2 (hu) 2001-09-28
HUP0004644A3 true HUP0004644A3 (en) 2002-01-28

Family

ID=27451698

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004644A HUP0004644A3 (en) 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase and pharmaceutical compositions containing them

Country Status (24)

Country Link
EP (1) EP1003748A2 (hu)
JP (1) JP2001515904A (hu)
KR (1) KR20010023766A (hu)
CN (1) CN1278820A (hu)
AP (1) AP2000001761A0 (hu)
AR (1) AR017072A1 (hu)
AU (1) AU9741298A (hu)
BR (1) BR9812062A (hu)
CA (1) CA2303176A1 (hu)
CO (1) CO4970719A1 (hu)
EA (1) EA200000204A1 (hu)
EE (1) EE200000138A (hu)
HU (1) HUP0004644A3 (hu)
ID (1) ID24452A (hu)
IL (1) IL134791A0 (hu)
IS (1) IS5391A (hu)
MA (1) MA26543A1 (hu)
NO (1) NO20001198L (hu)
NZ (1) NZ503130A (hu)
PE (1) PE107899A1 (hu)
PL (1) PL339176A1 (hu)
SK (1) SK3192000A3 (hu)
TR (1) TR200000907T2 (hu)
WO (1) WO1999012933A2 (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9905418D0 (en) * 1999-03-09 1999-05-05 Glaxo Group Ltd Process
US7429659B2 (en) 2004-03-31 2008-09-30 Janssen Pharmaceutica N.V. Furan compounds as histamine H3 modulators
DE102004024772A1 (de) * 2004-05-17 2005-12-22 Grünenthal GmbH Substituierte 5-Aminomethyl-1H-pyrrol-2-carbonsäureamide
JP4853759B2 (ja) * 2004-05-27 2012-01-11 日本農薬株式会社 置換ピラジンカルボン酸アニリド誘導体又はその塩類、その中間体及び農園芸用薬剤並びにその使用方法
TWI355380B (en) 2004-05-27 2012-01-01 Nihon Nohyaku Co Ltd Substituted pyrazinecarboxanilide derivatives or s
GB2418427A (en) 2004-09-02 2006-03-29 Univ Cambridge Tech Ligands for G-protein coupled receptors
ATE439347T1 (de) 2004-11-23 2009-08-15 Warner Lambert Co 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptansäure- derivate als hmg-co-a-reductase-inhibitoren zur behandlung von lipidemia
US8198288B2 (en) 2006-05-04 2012-06-12 Pulmagen Therapeutics (Inflammation) Limited Tetrahydropyrrolopyrimidinediones and their use in therapy
WO2007129060A1 (en) 2006-05-04 2007-11-15 Argenta Discovery Limited Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors
US7662967B2 (en) 2007-08-02 2010-02-16 Cambridge Enterprise Limited Anti-inflammatory compounds and compositions
GB2452696B (en) 2007-08-02 2009-09-23 Cambridge Entpr Ltd 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
WO2009060206A1 (en) * 2007-11-07 2009-05-14 Argenta Discovery Limited 3,4,6,7-tetrahydro-1h-pyrrolo[3,4-d]pyrimidine-2,5-diones and their therapeutic use
US20110212181A1 (en) * 2010-02-26 2011-09-01 The University Of Hong Kong Compositions and methods for treating chronic respiratory inflammation
JP2023500182A (ja) 2019-09-17 2023-01-05 メレオ バイオファーマ 4 リミテッド 移植片拒絶反応、閉塞性細気管支炎症候群、及び移植片対宿主病の治療に使用するためのアルベレスタット
DK4106757T3 (da) 2020-04-16 2023-10-23 Mereo Biopharma 4 Ltd Fremgangsmåder der involverer neutrofil elastase-inhibitor alvelestat til behandling af luftvejssygdom medieret af alpha-1-antitrypsin-mangel
CA3234399A1 (en) 2021-10-20 2023-04-27 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211783D0 (en) * 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
PL329153A1 (en) * 1996-03-28 1999-03-15 Glaxo Group Ltd Derivatives of pyrrolopyrolone as inhibitors of neutropil elastase

Also Published As

Publication number Publication date
WO1999012933A2 (en) 1999-03-18
KR20010023766A (ko) 2001-03-26
AU9741298A (en) 1999-03-29
MA26543A1 (fr) 2004-12-20
AP2000001761A0 (en) 2000-03-31
EA200000204A1 (ru) 2000-10-30
NO20001198D0 (no) 2000-03-08
BR9812062A (pt) 2000-09-26
HUP0004644A2 (hu) 2001-09-28
PE107899A1 (es) 1999-11-17
CO4970719A1 (es) 2000-11-07
ID24452A (id) 2000-07-20
AR017072A1 (es) 2001-08-22
JP2001515904A (ja) 2001-09-25
CA2303176A1 (en) 1999-03-18
CN1278820A (zh) 2001-01-03
NZ503130A (en) 2001-08-31
NO20001198L (no) 2000-05-08
SK3192000A3 (en) 2001-03-12
WO1999012933A3 (en) 1999-05-27
IL134791A0 (en) 2001-04-30
TR200000907T2 (tr) 2000-11-21
PL339176A1 (en) 2000-12-04
EP1003748A2 (en) 2000-05-31
IS5391A (is) 2000-02-29
EE200000138A (et) 2001-02-15

Similar Documents

Publication Publication Date Title
HUP9702035A3 (en) Inhibitors of leukocita-adhesion- and vla-4-antagonists and pharmaceutical compositions containing them
HUP9702036A3 (en) Inhibitors of leucocita-adhesion and wla-4-antagonists and pharmaceutical compositions containing them
HUP9702034A3 (en) Inhibitors of leukocita-adhesion and vla-4-antagonists and pharmaceutical compositions containing them
HUP9900964A3 (en) Protease inhibitors and pharmaceutical compositions containing these compounds
HUP0101810A3 (en) Substituted oxoazaheterocyclyl factor xa inhibitors and pharmaceutical compositions containing them
IL133613A0 (en) Epothilone derivatives and pharmaceutical compositions containing same
HUP0100178A3 (en) Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof
IL126674A0 (en) Urea derivatives as inhibitors of impdh enzyme and pharmaceutical compositions containing the same
HUP0102514A3 (en) Pyrido-pyrimidin and pyrimido-pyrimidin derivatives as inhibitors of cellular proliferation and pharmaceutical compositions thereof
HUP9802417A3 (en) Amide derivatives containing heteroaryl group and pharmaceutical compositions containing them
HUP0102990A3 (en) Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
HUP0000979A3 (en) Pharmaceutical compositions containing fk-506 and derivatives thereof
IL119466A0 (en) Thrombin inhibitors their preparation and pharmaceutical compositions containing them
HUP0002510A3 (en) Tetrazole derivatives and pharmaceutical compositions containing them
HUP0105160A3 (en) Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-betha-cyclodextrin or 2-hydroxypropyl-betha-cyclodextrin and method for its preparation and pharmaceutical compositions containing them
HUP9900567A3 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds
HUP0101381A3 (en) Benzofurylpyrone derivatives and pharmaceutical compositions containing them
HUP0004644A3 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase and pharmaceutical compositions containing them
HUP0002951A3 (en) Bis-aminomethylcarbonyl compounds as protease inhibitors and pharmaceutical compositions containing them
HUP0002324A3 (en) Benzimidazole derivatives and pharmaceutical compositions containing them
HUP9700005A3 (en) 2-ureido-benzamide derivatives and pharmaceutical compositions containing them as active agent
HUP0103203A3 (en) Azaadamantane derivatives and pharmaceutical compositions thereof
ZA967800B (en) Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them
HUP0100085A3 (en) Biphenylamidine derivatives and pharmaceutical compositions containing them
HUP0002331A3 (en) 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof